High-mobility group box 1-mediated microglial activation induces anxiodepressive-like behaviors in mice with neuropathic pain

[1]  L. Ryskalin,et al.  mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders , 2018, International journal of molecular sciences.

[2]  P. Veinante,et al.  Hyperactivity of Anterior Cingulate Cortex Areas 24a/24b Drives Chronic Pain-Induced Anxiodepressive-like Consequences , 2018, The Journal of Neuroscience.

[3]  R. Duman,et al.  Persistent Increase in Microglial RAGE Contributes to Chronic Stress–Induced Priming of Depressive-like Behavior , 2018, Biological Psychiatry.

[4]  Yong-Jie Lian,et al.  HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway , 2017, Brain, Behavior, and Immunity.

[5]  F. Gao,et al.  Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy , 2017, Brain, Behavior, and Immunity.

[6]  M. Ohsawa,et al.  Role of microglia in mechanical allodynia in the anterior cingulate cortex. , 2017, Journal of pharmacological sciences.

[7]  Charles C Lee,et al.  Stress-altered synaptic plasticity and DAMP signaling in the hippocampus-PFC axis; elucidating the significance of IGF-1/IGF-1R/CaMKIIα expression in neural changes associated with a prolonged exposure therapy , 2017, Neuroscience.

[8]  C. Cahill,et al.  Topography of microglial activation in sensory‐ and affect‐related brain regions in chronic pain , 2017, Journal of neuroscience research.

[9]  T. Yoshino,et al.  Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice , 2017, Scientific Reports.

[10]  W. Pan,et al.  Spared Nerve Injury Increases the Expression of Microglia M1 Markers in the Prefrontal Cortex of Rats and Provokes Depression-Like Behaviors , 2017, Front. Neurosci..

[11]  M. Nishibori,et al.  Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats , 2017, Scientific Reports.

[12]  H. Gong,et al.  Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1 , 2017, Brain, Behavior, and Immunity.

[13]  R. Cui,et al.  The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex , 2017, Neural plasticity.

[14]  M. Mattson,et al.  TNF-α Differentially Regulates Synaptic Plasticity in the Hippocampus and Spinal Cord by Microglia-Dependent Mechanisms after Peripheral Nerve Injury , 2017, The Journal of Neuroscience.

[15]  S. Skaper.  Mast Cell - Glia Dialogue in Chronic Pain and Neuropathic Pain: Blood-Brain Barrier Implications. , 2016, CNS & neurological disorders drug targets.

[16]  I. Wilson,et al.  HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia. , 2016, Cell reports.

[17]  M. Bianchi,et al.  HMGB1 as biomarker and drug target. , 2016, Pharmacological research.

[18]  Min Zhuo,et al.  Synaptic plasticity in the anterior cingulate cortex in acute and chronic pain , 2016, Nature Reviews Neuroscience.

[19]  M. Nishibori,et al.  Perineural expression of high‐mobility group box‐1 contributes to long‐lasting mechanical hypersensitivity via matrix metalloprotease‐9 up‐regulation in mice with painful peripheral neuropathy , 2016, Journal of neurochemistry.

[20]  M. Nishibori,et al.  Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease , 2016, Experimental Neurology.

[21]  Bing Huang,et al.  Glial activation in the periaqueductal gray promotes descending facilitation of neuropathic pain through the p38 MAPK signaling pathway , 2016, Journal of neuroscience research.

[22]  C. W. Nogueira,et al.  m-Trifluoromethyl-diphenyl diselenide, a multi-target selenium compound, prevented mechanical allodynia and depressive-like behavior in a mouse comorbid pain and depression model , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[23]  R. Yirmiya,et al.  Depression as a Microglial Disease , 2015, Trends in Neurosciences.

[24]  N. Morioka,et al.  Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice , 2015, Brain, Behavior, and Immunity.

[25]  M. Olmstead,et al.  Neurobiology of Disease Microglia Disrupt Mesolimbic Reward Circuitry in Chronic Pain , 2015 .

[26]  K. Mojumdar,et al.  Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. , 2015, Human molecular genetics.

[27]  B. Rosen,et al.  Evidence for brain glial activation in chronic pain patients. , 2015, Brain : a journal of neurology.

[28]  Alan A. Wilson,et al.  Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. , 2015, JAMA psychiatry.

[29]  M. Barrot,et al.  The Anterior Cingulate Cortex Is a Critical Hub for Pain-Induced Depression , 2015, Biological Psychiatry.

[30]  Haichao Wang,et al.  HMGB1 in health and disease. , 2014, Molecular aspects of medicine.

[31]  D. Finn,et al.  Minocycline modulates neuropathic pain behaviour and cortical M1–M2 microglial gene expression in a rat model of depression , 2014, Brain, Behavior, and Immunity.

[32]  Paul D. Morton,et al.  Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling , 2014, Brain, Behavior, and Immunity.

[33]  C. Svensson,et al.  Extracellular High-Mobility Group Box 1 Protein (HMGB1) as a Mediator of Persistent Pain , 2014, Molecular medicine.

[34]  E. Walters.  Neuroinflammatory contributions to pain after SCI: Roles for central glial mechanisms and nociceptor-mediated host defense , 2014, Experimental Neurology.

[35]  Ping Liu,et al.  Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review , 2014, BioMed research international.

[36]  M. Maze,et al.  High-mobility Group Box 1 Protein Initiates Postoperative Cognitive Decline by Engaging Bone Marrow–derived Macrophages , 2014, Anesthesiology.

[37]  Ming-Gang Liu,et al.  Preclinical research on pain comorbidity with affective disorders and cognitive deficits: Challenges and perspectives , 2014, Progress in Neurobiology.

[38]  M. Cordero,et al.  NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder , 2014, Brain, Behavior, and Immunity.

[39]  R. Dantzer,et al.  Neuroinflammation and Comorbidity of Pain and Depression , 2014, Pharmacological Reviews.

[40]  N. Kiguchi,et al.  HMGB1 as a potential therapeutic target for neuropathic pain. , 2013, Journal of pharmacological sciences.

[41]  Orrin Devinsky,et al.  Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence , 2013, Journal of Neuroinflammation.

[42]  N. Attal,et al.  Psychiatric co‐morbidities in patients with chronic peripheral neuropathic pain: A multicentre cohort study , 2013, European journal of pain.

[43]  L. Sansing,et al.  Microglial Responses after Ischemic Stroke and Intracerebral Hemorrhage , 2013, Clinical & developmental immunology.

[44]  M. Nishibori,et al.  Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1 , 2013, PloS one.

[45]  P. Sacerdote,et al.  Cytokine Modulation is Necessary for Efficacious Treatment of Experimental Neuropathic Pain , 2013, Journal of Neuroimmune Pharmacology.

[46]  N. Terrando,et al.  Surgery Upregulates High Mobility Group Box‐1 and Disrupts the Blood–Brain Barrier causing Cognitive Dysfunction in Aged Rats , 2012, CNS neuroscience & therapeutics.

[47]  A. Ohtsuka,et al.  Anti–high mobility group box‐1 antibody therapy for traumatic brain injury , 2012, Annals of neurology.

[48]  Shuxing Wang,et al.  Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. , 2012, The Journal of clinical investigation.

[49]  Xu-de Sun,et al.  High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes , 2012, Brain Research Bulletin.

[50]  M. Schachner,et al.  HMGB1 in Development and Diseases of the Central Nervous System , 2012, Molecular Neurobiology.

[51]  L. Garcia-Segura,et al.  Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice , 2012, Journal of Neuroinflammation.

[52]  Y. Kase,et al.  The Blood–Brain Barrier Permeability of 18β-Glycyrrhetinic Acid, a Major Metabolite of Glycyrrhizin in Glycyrrhiza Root, a Constituent of the Traditional Japanese Medicine Yokukansan , 2012, Cellular and Molecular Neurobiology.

[53]  M. Barrot,et al.  A Time-Dependent History of Mood Disorders in a Murine Model of Neuropathic Pain , 2011, Biological Psychiatry.

[54]  Andrew H. Miller,et al.  Immune system to brain signaling: neuropsychopharmacological implications. , 2011, Pharmacology & therapeutics.

[55]  A. Ohtsuka,et al.  Anti-high Mobility Group Box-1 Monoclonal Antibody Protects the Blood–Brain Barrier From Ischemia-Induced Disruption in Rats , 2011, Stroke.

[56]  K. Tracey,et al.  EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. , 2011, Biochemical pharmacology.

[57]  R. Dantzer,et al.  Inflammation-associated depression: From serotonin to kynurenine , 2011, Psychoneuroendocrinology.

[58]  K. Tracey,et al.  HMGB1 is a therapeutic target for sterile inflammation and infection. , 2011, Annual review of immunology.

[59]  R. Davidson,et al.  The integration of negative affect, pain and cognitive control in the cingulate cortex , 2011, Nature Reviews Neuroscience.

[60]  Takayoshi Suzuki,et al.  Epigenetic Status of Gdnf in the Ventral Striatum Determines Susceptibility and Adaptation to Daily Stressful Events , 2011, Neuron.

[61]  S. Kida,et al.  Impaired hippocampal spinogenesis and neurogenesis and altered affective behavior in mice lacking heat shock factor 1 , 2011, Proceedings of the National Academy of Sciences.

[62]  Sheng-Xi Wu,et al.  Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain. , 2010, Biochemical and biophysical research communications.

[63]  G. Norman,et al.  Stress and IL-1β contribute to the development of depressive-like behavior following peripheral nerve injury , 2010, Molecular Psychiatry.

[64]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[65]  Wayne Katon,et al.  Depression and pain. , 2009, Frontiers in bioscience.

[66]  M. Drew,et al.  Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression , 2009, Neuron.

[67]  J. Ochoa,et al.  NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES , 2009, Neurology.

[68]  A. Vania Apkarian,et al.  Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain , 2009, Proceedings of the National Academy of Sciences.

[69]  J. Dostrovsky,et al.  Neuropathic pain , 2008, Neurology.

[70]  T. Yoshino,et al.  Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  S. Barger,et al.  Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation , 2007, Journal of neurochemistry.

[72]  J. Girard.  A direct inhibitor of HMGB1 cytokine. , 2007, Chemistry & biology.

[73]  M. Zamai,et al.  Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities. , 2007, Chemistry & biology.

[74]  Rajagopal N. Aravalli,et al.  Toll-like Receptors in Defense and Damage of the Central Nervous System , 2007, Journal of Neuroimmune Pharmacology.

[75]  J. Panksepp,et al.  Modeling depression: social dominance–submission gene expression patterns in rat neocortex , 2006, Neuroscience.

[76]  M. Raiteri,et al.  Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein , 2006, Journal of neurochemistry.

[77]  L. Ulloa,et al.  High-mobility group box 1 (HMGB1) protein: friend and foe. , 2006, Cytokine & growth factor reviews.

[78]  Michael J. Constantino,et al.  Comorbid Depression, Chronic Pain, and Disability in Primary Care , 2006, Psychosomatic medicine.

[79]  F. Dhabhar,et al.  The adrenal gland is a source of stress-induced circulating IL-18 , 2006, Journal of Neuroimmunology.

[80]  Danielle L. Graham,et al.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.

[81]  John F. Cryan,et al.  Model organisms: The ascent of mouse: advances in modelling human depression and anxiety , 2005, Nature Reviews Drug Discovery.

[82]  M. Saeedi,et al.  The treatment of atopic dermatitis with licorice gel , 2003, The Journal of dermatological treatment.

[83]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[84]  H. Doerr,et al.  Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus , 2003, The Lancet.

[85]  S. File,et al.  A review of 25 years of the social interaction test. , 2003, European journal of pharmacology.

[86]  K. Tracey,et al.  HMGB1 as a DNA‐binding cytokine , 2002, Journal of leukocyte biology.

[87]  Y. Imai,et al.  Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1 , 2002, Glia.

[88]  Robert J Gatchel,et al.  Chronic Pain and Psychopathology: Research Findings and Theoretical Considerations , 2002, Psychosomatic medicine.

[89]  J Meulenbelt,et al.  THE PHARMACOKINETICS OF GLYCYRRHIZIC ACID EVALUATED BY PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING† , 2001, Drug metabolism reviews.

[90]  W. Hop,et al.  Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial , 1999, Journal of gastroenterology and hepatology.

[91]  H. Kotaki,et al.  Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability. , 1995, Biological & pharmaceutical bulletin.

[92]  R. Dworkin,et al.  Clinical aspects of depression in chronic pain patients. , 1991, The Clinical journal of pain.

[93]  Jin-Young Park,et al.  Local Interleukin-18 System in the Basolateral Amygdala Regulates Susceptibility to Chronic Stress , 2016, Molecular Neurobiology.

[94]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[95]  P. Buckley.  Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat StressBerton O, McClung CA, DiLeone RJ, et al (Univ of Texas Southwestern Med Ctr, Dallas; Tufts Univ School of Medicine, Boston) Science 311:864–868, 2006§ , 2007 .